Medication info
Olmex 40 mg (Olmesartan Medoxomil)

Olmex 40 mg (Olmesartan Medoxomil)

Prescription medicationTabletOral
Ingredient · strength
Olmesartan Medoxomil›40mg / 1 tablet
Manufacturer / importer
JW Pharmaceutical Corp.
Appearance
White oval film-coated tablets
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201100794 · Approved 2011.02.21 · Insurance code 644913300

Summary

Main use
Treatment of essential hypertension
Who takes it
Adults · Children
Adult dose
<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If additional blood pressure reduction is required, the dose may be increased up to a maximum of 40mg per day. The antihypertensive effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered concomitantly with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended to take the drug at the same time each day (e.g., in the morning), if possible. For patients who may have intravascular volume depletion (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. <Older adults> No dose adjustment is required when administering this drug to older adults aged 65 years or older. No overall differences in the efficacy or safety of this drug have been observed between older and younger patients; however, a more sensitive response in some older patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is required for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and the dose may be increased up to a maximum of 20mg per day. Use is not recommended in patients with severe hepatic impairment because there is no experience with its use in these patients.
Child dose
Safety and efficacy for pediatric use have not been established.

Ingredients

Manufacturer
JW Pharmaceutical Corp.

Efficacy & effects

Treatment of essential hypertension

  • Essential hypertension
View approved original text

Essential hypertension is a condition that is very important for reducing the burden on the heart and blood vessels by controlling blood pressure within a normal range, and for preventing complications. This medication is used in the treatment of essential hypertension to lower blood pressure and improve cardiovascular health. Continuous use of this medication reduces the risk of stroke, myocardial infarction, and contributes to improving the overall quality of life of patients. This medication is used for the effective management of essential hypertension.

How to take

Adult dose

<Adults> The recommended initial dose is 10mg once daily, with or without food. If blood pressure is not adequately controlled at this dose, increase to 20mg once daily. If additional blood pressure reduction is required, the dose may be increased up to a maximum of 40mg per day. The antihypertensive effect appears within 2 weeks after starting treatment and reaches its maximum effect at approximately 8 weeks. If blood pressure is not controlled with this drug alone, it may be administered concomitantly with a thiazide diuretic such as hydrochlorothiazide. To improve adherence, it is recommended to take the drug at the same time each day (e.g., in the morning), if possible. For patients who may have intravascular volume depletion (e.g., patients receiving diuretics, particularly those with renal impairment), it is recommended to initiate treatment at a low dose while closely monitoring their condition. <Older adults> No dose adjustment is required when administering this drug to older adults aged 65 years or older. No overall differences in the efficacy or safety of this drug have been observed between older and younger patients; however, a more sensitive response in some older patients cannot be ruled out. <Patients with renal impairment> The maximum dose for patients with mild to moderate renal impairment (creatinine clearance 20-60mL/min) is 20mg once daily. <Patients with hepatic impairment> No dose adjustment is required for patients with mild hepatic impairment. The recommended initial dose for patients with moderate hepatic impairment is 10mg once daily, and the dose may be increased up to a maximum of 20mg per day. Use is not recommended in patients with severe hepatic impairment because there is no experience with its use in these patients.

Child dose

Safety and efficacy for pediatric use have not been established.

Precautions

This medication can seriously harm the fetus and newborn if taken during the second and third trimesters of pregnancy, so it must be discontinued immediately if pregnancy is confirmed. Do not take this medication if you have an allergy to any of its components, are pregnant, or are breastfeeding. It should not be administered to patients receiving kidney dialysis, those with severe liver disease, patients with biliary obstruction, or those with certain genetic lactase deficiency. Diabetic patients taking aliskiren formulations or those with moderate to severe renal impairment should not take this medication. Patients with reduced blood volume or salt may experience hypotension during the initial stages of treatment with this medication, so their condition should be carefully assessed, and appropriate measures should be taken if necessary. Patients with severe congestive heart failure or those whose kidney function depends on the renin-angiotensin-aldosterone system may experience changes in renal function, so caution is required. Patients with poor renal function should have their potassium and creatinine levels regularly checked by blood tests, and this medication is not recommended for patients with severe renal impairment. Patients with renal artery stenosis should be cautious about the risk of worsening kidney function with prolonged use. This medication may increase serum potassium levels, so patients with heart failure or renal impairment should frequently check their potassium levels. Patients with aortic or mitral valve stenosis, obstructive or hypertrophic cardiomyopathy should exercise special caution when using this medication. Patients with primary aldosteronism may not respond to this medication, and its use is not recommended. This medication has a blood pressure-lowering effect that may cause dizziness, so caution should be taken when driving or operating hazardous machinery. The effect of blood pressure lowering may be increased if this medication is used with other antihypertensive medications, so it should be discussed with a physician. Taking this medication with potassium-sparing diuretics or potassium supplements can lead to dangerously elevated potassium levels. Avoid using it with lithium as it may increase lithium levels and cause toxicity. Caution is advised when used with non-steroidal anti-inflammatory drugs (NSAIDs) as it may worsen kidney function. Taking this medication concurrently with angiotensin-converting enzyme inhibitors or aliskiren increases the risk of hypotension, hyperkalemia, and renal impairment, so co-administration should be avoided. This medication is minimally metabolized in the liver, leading to fewer interactions with other medications, but if abnormal symptoms occur during use, consult medical professionals immediately. If symptoms like chronic diarrhea, abdominal pain, or weight loss occur during treatment, inform the physician immediately as there may be a possibility of chronic malabsorption-like intestinal disorder. Rarely, angioedema or allergic reactions may occur after taking this medication, so if swelling of the face or neck or difficulty breathing appears, immediate emergency treatment is required. Taking this medication during pregnancy can result in severe problems such as renal impairment of the fetus, oligohydramnios, or craniofacial malformations, so it should never be taken during pregnancy. If breastfeeding, this medication may pass into breast milk and cause adverse reactions in the baby, so breastfeeding should be discontinued or this medication should be paused. Safety and efficacy for pediatric use have not been established, so it is advisable to avoid use in children. Elderly patients may have higher drug concentrations, so dosage adjustments may be necessary.

Side effects

dizziness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be kept in a tightly sealed container to prevent exposure to air or moisture. It should be stored at room temperature between 1°C and 25°C to maintain its effectiveness.

Appearance and packaging

Appearance

White oval film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.